Lv3
394 积分 2024-01-29 加入
Design and Discovery of Preclinical Candidate LYG-409 as a Highly Potent and Selective GSPT1 Molecular Glue Degraders
1天前
待确认
Site-Selective Antibody–Drug Conjugation by a Proximity-Driven S to N Acyl Transfer Reaction on a Therapeutic Antibody
2个月前
已完结
Site-Selective Anti-PD-L1 Antibody–MMAE Conjugate for Enhanced NSCLC Therapy
2个月前
已完结
Rational Design of Dual Degraders by Incorporating Molecular Glue Structural Features into PROTAC Degraders
2个月前
已完结
A Dual-Targeted Molecule for Disease-Activatable Proteolysis Targeting Chimeras and Targeted Radionuclide Therapy of Cancer
3个月前
已完结
DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications
3个月前
已完结
Exploiting Synthetic Lethality in PDAC with Antibody Drug Conjugates and ATR inhibition
3个月前
已完结
Modular Synthesis of Anti-HER2 Dual-Drug Antibody-Drug Conjugates Demonstrating Improved Toxicity
3个月前
已完结
Synthesis of Spiroborate Esters from 1,2‐Aminoalcohols, Ethylene Glycol and Triisopropyl Borate: Preparation of (S)‐1‐(1,3,2‐Dioxaborolan‐2‐yloxy)‐3‐Methyl‐1,1‐Diphenylbutan‐2‐Amine
3个月前
已关闭
NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate
3个月前
已完结
皖公网安备34019202002308
